FDA Approves Leqselvi for Severe Alopecia
JAK inhibitor associated with significant improvements in scalp hair coverage at 24 weeks
FDA Warns Against Using Chemical Peels Without Professional Supervision
People who are buying and using at-home chemical peels are ending up burned and scarred
CDC Report Addresses Nonfinancial Access Barriers to Care in 2022
12.5 percent of U.S. adults delayed or did not get medical care in past 12 months because they were too busy to go to a provider
Relatively High Frequency of Emergency Complications Seen for Dermatological Procedures
53 percent of dermatologists reported emergency complications during dermatological and surgical procedures; 43.2 percent during cosmetic procedures
Gen Z Perceives Atopic Dermatitis to Be More Severe
Perceived severity higher among Gen Z compared with millennial patients
Atopic Dermatitis Has Large Impact on Sexual Function Among Women
About half of women considered that atopic dermatitis may influence their gestational desire
Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy
However, increased risk seems to be linked to the higher prevalence of contributing factors for polyneuropathy
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen Sclerosus
Response rate higher for anogenital versus extragenital lichen sclerosus
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema
Authors suggest limiting duration of oral corticosteroid treatment to 90 days or less to reduce risk of adverse effects
Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun Climate
Low sun-exposure group had significantly lower total dose requirements in multivariable analyses correcting for age
